Related by context. All words. (Click for frequent words.) 67 Hb A1C 66 hemoglobin Hb 66 nondiabetic patients 66 undetectable viral 66 SGPT 66 gm dL 65 μmol L 65 HbA 1c levels 65 glycated hemoglobin levels 65 g dl 65 alanine aminotransferase 65 alanine aminotransferase ALT 65 mmol l 64 ß blockers 64 leukocyte count 64 mmHg diastolic 64 AST ALT 64 nicardipine 64 1c HbA 1c 64 aspartate aminotransferase AST 64 sodium nitroprusside 64 HbA 1c 64 iPTH 64 fosamprenavir 64 % CI #.#-#.# [008] 63 aspartate aminotransferase 63 elevated ALT 63 serum urate levels 63 vasopressor 63 serum lipid levels 63 μg kg 63 HbA1C levels 63 pg ml 63 HBeAg negative patients 63 serum retinol 63 tipranavir r 63 glycosylated hemoglobin HbA1c 63 serum ALT 63 HbA1C 62 μg L 62 salmeterol fluticasone 62 mL/min/#.# m 2 62 baseline HbA1c 62 mIU L 62 serum IGF 62 serum potassium 62 neutrophil counts 62 anemia hemoglobin 62 Plasma concentrations 62 pT3 62 titrated glipizide 62 NNT = 62 μg mL 62 serum creatinine levels 62 creatine kinase 62 fluvastatin 62 atazanavir ritonavir 62 anagrelide 62 ALT elevation 62 seropositivity 62 serum uric acid 62 experienced virologic failure 62 dalteparin 62 glycated hemoglobin HbA1c 62 albumin excretion 62 β blockers 62 glomerular filtration 62 serum LDL cholesterol 62 mcg BID 62 antibody titer 61 lactate dehydrogenase 61 pentoxifylline 61 irbesartan 61 pmol L 61 isoproterenol 61 hemoglobin A1c HbA1c 61 #.#mmol L [002] 61 elevated uric acid 61 elevated LDL cholesterol 61 plasma homocysteine 61 μg dl 61 atorvastatin #mg 61 SGOT 61 serum concentrations 61 IOP lowering 61 cTnI 61 glycated hemoglobin 61 Kinoid 61 Hb levels 61 p = NS 61 serum cortisol 61 serum magnesium 61 epoetin beta 61 mmol L. 61 elevated creatinine 61 urine albumin 61 mL/min/#.# m2 61 hydroxyvitamin D levels 61 chlorthalidone 61 poor metabolizers 61 Serum creatinine 61 HBeAg seroconversion 61 Hb A1c 60 HOMA IR 60 bioavailable testosterone 60 serum phosphate 60 hepatorenal syndrome 60 mean baseline HbA1c 60 plasma renin 60 uM 60 glycosylated hemoglobin 60 baseline serum creatinine 60 bisoprolol 60 mcg mL 60 hemoglobin concentration 60 baseline Hb 60 ULORIC 60 elevated LDH 60 posttreatment 60 #mmHg [001] 60 hemoglobin concentrations 60 cinacalcet 60 mmol liter 60 detemir 60 inflammatory biomarkers 60 inotropic 60 apolipoprotein B 60 fasting triglycerides 60 mm Hg systolic 60 oral antidiabetes 60 Flu Cy 60 ug kg 60 hemoglobin A1c levels 60 serum phosphate levels 60 troponin T 60 nmol 60 symptomatic intracranial hemorrhage 60 transaminase elevations 60 umol L 60 insulin glulisine 60 hsCRP levels 60 % CI #.#-#.# [007] 60 nanograms milliliter 60 serum glucose 60 intact parathyroid hormone 60 Fasting plasma glucose 60 Interferon beta 1b 60 x ULN 60 hypophosphatemia 60 serum lactate 60 Platelet counts 60 relapsed MM 60 HSCT 60 anti HBs 60 fluticasone salmeterol 60 abacavir Ziagen 60 posttransplant 60 tHcy 60 procalcitonin 60 serum estradiol 60 sitosterol 60 serum albumin 60 mmHg systolic 60 eosinophil count 60 μg ml 60 methylmalonic acid 60 parasitemia 60 euthyroid 59 μg d 59 steroid dexamethasone 59 nitroprusside 59 malondialdehyde MDA 59 dose atorvastatin 59 #ng/ml 59 piperacillin tazobactam 59 ritonavir boosted 59 CsA 59 unfractionated heparin UFH 59 achieved ACR# 59 -#.# mg dL [002] 59 pg mL 59 sirolimus stent 59 ertapenem 59 -#.# log# 59 oral antidiabetic medication 59 fasting plasma 59 baseline LDH 59 aminotransferases 59 clomipramine 59 mIU ml 59 HBeAg 59 isoprostane 59 hydroxyprogesterone 59 creatinine levels 59 DAS# CRP 59 ALT AST 59 mEq L 59 loop diuretics 59 certolizumab 59 improves glycemic 59 mg kg Hematide 59 transaminases 59 K DOQI guidelines 59 transferrin saturation 59 BENICAR HCT 59 Cystatin C 59 abacavir lamivudine 59 rapid virological response 59 mg/m2 dose 59 isolated systolic hypertension 59 thrombocytopenic 59 #.#mg/dL 59 PSA nadir 59 achieving PASI 59 serum insulin 59 comparator arm 59 tolterodine ER 59 bronchial hyperresponsiveness 59 glomerular filtration rate 59 Hematocrit 59 biochemical relapse 59 SCr 59 mU L 59 sitaxsentan 59 nitrofurantoin 59 lymphocytosis 59 estimated GFR 59 mg kg dose 59 μg dL 59 lymphocyte count 59 aminotransferase 59 paricalcitol 59 beta blocker therapy 59 tranylcypromine 59 complete cytogenetic response 59 serum triglyceride levels 59 plasma cortisol 59 corticosteroid dose 59 TMP SMX 59 onset diabetes mellitus 59 oral prednisolone 59 HGPIN 59 elevated fasting glucose 59 serum homocysteine 59 normoxic 59 severe exacerbations 59 imipenem 59 statistically significant predictor 59 pulmonary capillary wedge 59 alkaline phosphatase 59 primary aldosteronism 59 polyp recurrence 59 nmol l 59 albumin excretion rate 59 glulisine 59 #/#mmHg 59 HER2 expression 59 preintervention 59 nmol liter 59 ATACAND 59 mcg dL 59 haematologic 59 postprocedure 58 lactate dehydrogenase LDH 58 nonobese 58 elevated serum creatinine 58 pCR 58 tirofiban 58 eplerenone 58 p = ns 58 moderately emetogenic 58 urinary albumin excretion 58 serum aminotransferase levels 58 bronchoalveolar lavage 58 tacrolimus ointment 58 atherosclerotic renal artery stenosis 58 neurodevelopmental impairment 58 sUA 58 dehydroepiandrosterone sulfate 58 μg l 58 p = #.# [003] 58 ritonavir boosted lopinavir 58 hematological parameters 58 CCyR 58 serum TSH 58 % Confidence Interval 58 serum ferritin 58 PASI scores 58 acylated ghrelin 58 folate concentrations 58 lumbar spine BMD 58 cilostazol 58 hepatic enzymes 58 antithyroid 58 mIU mL 58 perioperatively 58 pamidronate 58 acetazolamide 58 nmol L. 58 nondiabetics 58 monoclonal immunoglobulin 58 symptomatic hypotension 58 thiazide 58 salmeterol fluticasone propionate 58 trimethoprim sulfamethoxazole 58 nephrotoxicity 58 Fasting blood glucose 58 intima media thickness 58 fasting triglyceride levels 58 Serum calcium 58 DAS# remission 58 serum PTH 58 efavirenz EFV 58 leukocyte counts 58 Creatinine 58 bezafibrate 58 BARACLUDE ® 58 #mg dose [002] 58 periprocedural 58 mcg QD 58 hematologic abnormalities 58 HbA1c levels 58 alpha1 58 pegylated IFN 58 timolol maleate 58 nonsignificant difference 58 acarbose 58 candesartan cilexetil 58 ECOG PS 58 #mg BID [001] 58 ARCOXIA 58 serum testosterone 58 serum calcium 58 HIV HCV coinfected 58 MULTAQ 58 mcg ml 58 nadroparin 58 serum phosphorus levels 58 elevated troponin 58 achieved CCyR 58 indinavir 58 KDOQI 58 #OHD levels 58 lispro 58 serum sodium levels 58 systemic corticosteroids 58 nonnucleoside reverse transcriptase inhibitors 58 serum bilirubin 58 creatine kinase CK 58 sustained virological response 58 creatine phosphokinase 58 triacylglycerol concentrations 58 mmHg p = 58 ALT elevations 58 CrCl 58 oxycodone CR 58 echocardiographic parameters 58 Fasting glucose 58 prolactin elevation 58 elevated homocysteine 58 AUC0 58 aldosterone antagonist 58 imiquimod cream 58 statistical significance p 58 CK MB 58 liver histology 58 lipid elevations 58 rizatriptan 58 plasma uric acid 58 pT2 58 leucopenia 58 serum lipid 58 intravenous diuretics 58 NYHA functional class 58 octreotide LAR 58 seroprotection 58 IDDM 58 arterial thromboembolic events 58 calculated creatinine clearance 58 rHuEPO 57 pretest probability 57 microgram kg 57 blood phenylalanine Phe 57 PCWP 57 leukopenia 57 serum triglycerides 57 PRADAXA #mg 57 virological suppression 57 myeloperoxidase 57 homocysteine concentrations 57 #mg doses [002] 57 preoperative PSA 57 noninferior 57 receptor blocker 57 elevated transaminases 57 achieved statistical significance 57 GG genotype 57 partial thromboplastin 57 UGT#A# * 57 pmol liter 57 microg 57 serum phosphorus 57 FluCAM arm 57 MMSE score 57 pretransplant 57 PaO 2 57 platelet reactivity 57 Captopril 57 statin monotherapy 57 ACE Inhibitor 57 creatinine ratio 57 Elevated serum 57 divalproex sodium 57 TT genotype 57 adalimumab Humira 57 antigen PSA levels 57 hepatic enzyme 57 #beta 57 OGTT 57 lowest tertile 57 RBC transfusion 57 IFN beta 57 SCIg 57 intracranial hemorrhage ICH 57 μmol l 57 serum urate 57 #mg/day [002] 57 human chorionic gonadotropin hCG 57 liver transaminases 57 mU liter 57 low dose Iluvien 57 lopinavir r arm 57 plasma folate 57 Ishak fibrosis score 57 D dimer 57 hip resurfacing arthroplasty 57 monoinfected patients 57 Noxafil 57 idraparinux 57 folic acid vitamin B# 57 % CI #.#-#.# [006] 57 hypercholesterolaemia 57 nmol L 57 Microalbuminuria 57 daily subcutaneous injections 57 interquartile range 57 plasma lipids 57 colorectal adenoma 57 μg liter 57 4mg/kg 57 median survivals 57 interleukin IL -6 57 rimonabant #mg 57 anastomotic leak 57 genotypic resistance 57 undetectable HBV DNA 57 #mg/dl 57 Engerix B 57 glycemia 57 rheumatoid factor 57 INVEGA ® 57 overt nephropathy 57 ng dL 57 Hypotension 57 CR nPR 57 ddI 57 TPV r 57 graft occlusion 57 leukocytosis 57 ng mL 57 LV dysfunction 57 mg XP# 57 tapentadol ER 57 reactogenicity 57 postoperative morbidity 57 bacteremic 57 intratympanic 57 lupus anticoagulant 57 plasma pharmacokinetics 57 ara C 57 Moxifloxacin 57 serum calcium levels 57 Avandia Actos 57 Nebulized 57 multivariable adjusted 57 serum sodium 57 thyrotropin 57 #OHD 57 pimecrolimus cream 57 plasma triglycerides 57 anti Xa 57 tryptase 57 systemic hypotension 57 -#.# ± [002] 57 coronary stenosis 57 dose Iluvien 57 MCyR 57 hematologic toxicity 57 amoxicillin clavulanate 57 pg g 57 hypervolemic 57 resected pancreatic cancer 57 mean baseline A1C 57 thyroglobulin 57 flutamide 57 mol L 57 SUVmax 57 LPV r 57 concomitant medications 57 polymyxin B 57 % CI #.#-#.# [003] 57 clinically evaluable patients 57 benazepril 57 binary restenosis 57 hemodilution 57 Lipitor #mg 57 Cmax 56 Parathyroid Hormone 56 triiodothyronine 56 oral diclofenac 56 malignant neoplasm 56 oral Hycamtin 56 heFH 56 estimated glomerular filtration 56 serum IgE 56 spirometric 56 mm Hg diastolic 56 hematopoietic cancers 56 LDL cholesterol HDL cholesterol 56 3mg/kg 56 #.#/#.# mm Hg [003] 56 0mg 56 systemic corticosteroid 56 Non inferiority 56 serum phosphorous 56 fasting glucose levels 56 Homocysteine levels 56 LDL triglycerides 56 angiotensin converting enzyme inhibitors 56 ug ml 56 dobutamine 56 receiving VICTRELIS 56 angiotensin converting enzyme 56 elevated IOP 56 tissue oxygenation 56 pulmonary arterial 56 REYATAZ r arm 56 hyperphenylalaninemia HPA due 56 macroalbuminuria 56 BLLs 56 Hb 56 Stent thrombosis 56 insulin detemir 56 diuretics beta blockers 56 A1c levels 56 mmol kg 56 IGFBP 56 hemoglobin hematocrit 56 N telopeptide 56 TURBT 56 PREZISTA r arm 56 #mg/day [001] 56 serum parathyroid hormone 56 HIV uninfected 56 hemoglobin Hb levels 56 recurrent UTI 56 fluorouracil leucovorin 56 NNRTI resistance 56 darbepoetin alpha 56 receiving Vectibix monotherapy 56 PEG IFN 56 arterial oxygen saturation 56 reticulocytes 56 AUCs 56 inhaled corticosteroids ICS 56 aminotransferase ALT 56 expressors 56 mild renal insufficiency 56 glycosylated hemoglobin levels 56 caspofungin 56 balsalazide 56 Dasatinib 56 Haemoglobin 56 elevated triglyceride levels 56 highest tertile 56 immunosuppressives 56 Proteinuria 56 p ≤ 56 serum folate 56 Interferon alfa 56 low dose ritonavir 56 gestational hypertension 56 ursodeoxycholic acid 56 thyroid stimulating hormone 56 hypokalemia 56 Hazard Ratio 56 Serum concentrations 56 aminotransferase levels 56 bFGF 56 thromboxane A2 56 intermittent dosing 56 rhEPO 56 olmesartan 56 total cholesterol triglycerides 56 pyridoxine 56 thyrotropin levels 56 induce orthostatic hypotension 56 SSc patients 56 lipid lowering agents 56 hemoglobin levels 56 QT interval prolongation 56 PANSS scores 56 Pred Forte 56 Cyclosporine 56 EDSS scores 56 fructosamine 56 IgG antibody 56 ergocalciferol 56 inhaled budesonide 56 surrogate markers 56 mg BID dose 56 blood glucose concentrations 56 mL kg 56 QVAR R 56 ìg 56 advanced adenomas 56 serum CRP 56 advanced adenoma 56 elevated LDL 56 bovine thrombin 56 hours postdose 56 urinary iodine 56 nitrosothiols 56 Infusion Reactions Severe 56 p = .# [002] 56 nonadherent 56 mesilate 56 tertiles 56 postoperative complication 56 log# copies mL 56 postoperative mortality 56 renal insufficiency 56 alanine transaminase 56 Ki# 56 baroreflex sensitivity 56 perioperative mortality 56 doxazosin 56 diastolic blood pressures 56 lipid lowering medications 56 elevated CRP 56 DHEA supplementation 56 virologically 56 confidence intervals CIs 56 COPD exacerbation 56 kappa = 56 mean corpuscular volume 56 Linezolid 56 glucose insulin 56 electrical cardioversion 56 ximelagatran 56 moderate renal impairment 56 thromboembolic complications 56 plasma leptin 56 induced sputum 56 epoetin alfa 56 ALT normalization 56 triacylglycerol 56 thromboprophylaxis 56 Lp PLA 2 55 LDL Cholesterol 55 CTEPH 55 detectable HCV RNA 55 hypoglycemic events 55 vasoactive 55 K ras mutations 55 hyperkalemia 55 CVD mortality 55 PHPT 55 COHb 55 macrolide antibiotic 55 atherogenic dyslipidemia 55 ejection fractions 55 #dhTxB# 55 Hgb 55 digoxin toxicity 55 cefotaxime 55 diabetic kidney 55 metformin monotherapy 55 QTcF 55 bronchodilatory 55 riociguat 55 rhTSH 55 isoenzyme 55 log# reduction 55 International Normalized Ratio 55 serum selenium 55 sargramostim 55 #.#/#.# mmHg [001] 55 canakinumab 55 lopinavir 55 microbiological eradication 55 bacillus Calmette Guerin 55 beta adrenergic receptor 55 diastolic hypertension 55 mg/# hours 55 NPH insulin 55 angiotensin receptor blockers ARBs 55 Solid Tumors criteria 55 triglyceride concentrations 55 clodronate 55 mcg dose 55 urinary calcium 55 IU ml 55 exhaled NO 55 protein excretion 55 underwent surgical resection 55 Main Outcome Measure 55 oral anticoagulation 55 chloride secretion 55 regression coefficient 55 intravesical therapy 55 preterm neonates 55 hyperresponsiveness 55 HES CEL 55 β blocker 55 serum bicarbonate 55 serum triglyceride 55 G CSFs 55 nonobese patients 55 inversely associated 55 INCB# [003] 55 #mmHg [002] 55 dexamethasone Decadron 55 obstructive CAD 55 oxysterols 55 sensory neuropathy 55 #mg/dL [002] 55 cough dyspnea 55 lymphocyte counts 55 lowering blood glucose 55 IGFBP 3 55 pretreatment serum 55 bolus dose 55 preeclamptic 55 exhaled nitric oxide 55 recurrent venous thromboembolism 55 CIMZIA TM 55 mutated KRAS 55 symptomatic intracranial 55 subcutaneous insulin 55 stent binary restenosis 55 unresectable HCC 55 thiazides 55 postintervention 55 hyperlipemia 55 Bacteremia 55 ml kg 55 g dL 55 retransplantation 55 invasive aspergillosis 55 GH deficiency 55 Viral load 55 revascularizations 55 acromegalic patients 55 virologic failure 55 tuberculin skin testing 55 urinary excretion 55 NovoLog ® Mix 55 Pegasys peginterferon alfa 2a 55 Interferon Beta 55 μg g 55 MADRS score 55 microbiologically evaluable 55 artery stenosis 55 cytopenias 55 mCi kg 55 mcL 55 serum IgG 55 = #.#-#.# 55 doxorubicin docetaxel 55 rFVIIa 55 mcg albinterferon alfa 2b 55 tigecycline 55 diuretic chlorthalidone 55 Kaplan Meier estimates 55 mucosal inflammation 55 Posaconazole 55 Primary endpoints 55 #μg [001] 55 detrusor 55 mycophenolate 55 Mg Usa 55 univariate analysis 55 preterm newborns 55 glucocorticoid induced 55 hyperhomocysteinemia 55 antiphospholipid antibodies 55 seroconverted 55 ng ml 55 serum PSA 55 mycophenolate mofetil 55 hydroxyvitamin D concentrations 55 glucuronide 55 COZAAR 55 suboptimal adherence 55 Lovaza ® 55 Allogeneic 55 plasma homocysteine levels 55 chronic HBV 55 P = .# 55 oral allopurinol 55 reduce serum phosphate 55 Hypoglycaemia 55 atrophic gastritis 55 clinically meaningful reductions 55 multivariable analysis 55 ghrelin concentrations 55 mechanically ventilated patients 55 MIC# [001] 55 HER2 amplification 55 deletion 5q 55 SHBG levels 55 mEq L. 55 triglyceride TG 55 IFN alfa 55 lipoprotein Lp 55 TMC# r 55 Pharmacokinetic parameters 55 hematologic parameters 55 initiating antiretroviral therapy 55 specific antigen PSA 55 epoetin 55 beta interferons 55 serum GGT 55 BENICAR 55 adiponectin concentrations 55 submaximal exercise 55 Peg IFN 55 HBsAg 55 IV bisphosphonates 55 nitrotyrosine 55 heterozygotes 55 immunoglobulin G 55 sFlt 1 55 eosinophilia 55 elevated prolactin 55 Subgroup analyzes 55 Partial Response 55 cranial irradiation 55 renal toxicity 55 cefepime 55 beta carotene supplementation 55 TIMP 1 55 thrombocytosis 55 NRTI sparing 55 XIENCE V PROMUS Stent 55 sleeve lobectomy 55 HDL LDL 55 maximal doses 55 CI -#.# 55 APTIVUS 55 NAbs 55 coinfected patients 55 endothelium dependent 55 Erythropoietin 55 fasting plasma glucose FPG 55 HPV-#/# 55 CIN2 + 55 anthracycline chemotherapy 55 MBq 55 IIIa inhibitors 55 glutamyl 55 hydroxy vitamin D 55 ischemia driven 55 definite stent thrombosis 55 concentration Cmax 55 adverse cytogenetics 55 serum HBV DNA 54 airway hyper responsiveness 54 GnRH agonist 54 cytokine interleukin 54 Pegylated interferon 54 confidence interval #.#-#.# 54 depressive symptomatology 54 corticosteroid therapy 54 CD# upregulation 54 cholesterol LDL C 54 MELD scores 54 glargine 54 D Dimer 54 renal excretion 54 treat NNT 54 statistically significant p = 54 KRAS status 54 adjunctive placebo 54 systolic dysfunction 54 lopinavir r 54 A1Cs 54 #mg #mg #mg [003] 54 urinary cortisol 54 8 OHdG 54 urodynamic parameters 54 heparanase 54 virological response 54 timolol 54 HCV antibody 54 grade cervical intraepithelial 54 antihypertensive therapy 54 CI #.#-#.# [001] 54 hydroxylase 54 serum BDNF 54 Viread Emtriva 54 oocytes retrieved 54 prednisone prednisolone 54 nelfinavir 54 receiving ISENTRESS 54 Oxidized LDL 54 GERD symptom 54 d dimer 54 milliliters mL 54 hypercholesterolemic patients 54 hemoglobin A1C 54 null responder 54 oral hypoglycemic 54 mmol L 54 tipranavir ritonavir 54 salmeterol HFA MDI 54 sUA levels 54 specific IgE 54 CC genotype 54 serum thyroglobulin 54 timepoints 54 FeNO 54 latent celiac disease 54 P ≤ 54 macrovascular events 54 adrenal hormone 54 Aptivus ® 54 adefovir treated 54 GABHS 54 Pneumocystis carinii pneumonia 54 % CI #.#-#.# [004] 54 postprandial glycemia 54 Triamcinolone 54 TNFalpha 54 TEAEs 54 Thiazolidinediones 54 oral hypoglycemic agents 54 prospectively stratified 54 Skin sterol 54 intravenous dosing 54 inecalcitol 54 #mm Hg 54 polytherapy 54 carotid IMT 54 urate levels 54 hyperinsulinemic 54 dose statin therapy 54 Postoperative complications 54 unboosted 54 Xalatan R 54 renal tubular 54 containing abacavir 54 Adjuvant chemotherapy 54 nonsevere 54 fibrin deposition 54 sulfonylurea metformin 54 inotropic agents 54 metformin sulphonylurea 54 IFN α 54 fetuin 54 antiretroviral naïve 54 L glutamine 54 plasma lipid 54 Diastolic pressure 54 #ug [002] 54 quetiapine Seroquel 54 CIMZIA TM certolizumab pegol 54 ß amyloid 54 viral titers 54 revascularized 54 monocyte chemoattractant protein 54 NIHSS score 54 hypoxemia 54 interstitial pneumonia 54 glycoprotein IIb IIIa inhibitors 54 methylprednisolone 54 obstructive coronary artery 54 clinically evaluable 54 homozygotes 54 postprandial blood glucose 54 Vidaza azacitidine 54 imipramine Tofranil 54 ug g 54 Sevelamer 54 postdose 54 detrusor overactivity 54 rebleeding 54 paraprotein